Temperature storage

If you are looking for a FVIII product that's ready to go, controls bleeds, and has an established safety profile, Novoeight® offers all 3.

Meet Novoeight®

Is it time to reconsider your treatment for hemophilia A?

If you are looking for a FVIII product that's ready to go, controls bleeds, and has an established safety profile, Novoeight® offers all 3.

Meet Novoeight®


Malcolm lives with hemophilia A.
 

Need a treatment that's designed to go with you?

Novoeight® is the only standard half-life factor VIII with stability up to 104˚F for up to 3 months.a

See How It Compares


aCompared to other recombinant factor VIII products. Please see Prescribing Information for complete product storage instructions.

Silhouettes of 5 people standing together

How can we help?

Novo Nordisk Rare Blood Community Liaisons (RBCLs) are here to answer your questions about Novoeight® and connect you with resources to help you manage your bleeding disorder.

Connect with your RBCL

Does it fit my lifestyle?

Novoeight® offers the highest storage temperature after reconstitution—104˚F.a And it offers the longest room temperature storage time after reconstitution of any standard half-life factor—4 hours at up to 86˚F.a That’s why Novoeight® won’t slow you down when you’re on the go.

Find Out About Storage Flexibility

How does it work?

Novoeight® delivers reliable bleed control. It was proven effective in one of the largest clinical trial programs to date.

Learn About Bleed Control


David lives with hemophilia A.


David lives with hemophilia A.

Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]

Standard Half-Life or

Extended Half-Life?

We make Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] by taking the existing Novoeight® molecule and adding PEGylation technology to extend its half-life. Are you interested in up to 50% fewer infusions and factor levels that stay at or above 3% for 100% of the time?b,c

Discover Esperoct®

Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] 1000 IU medication

bTrough level goal is 1% for prophylaxis
cData shown are from a study where 175 previously treated adolescents and adults received routine prophylaxis with Esperoct® 50 IU/kg every 4 days for 76 weeks. Pre-dose factor activity (trough) levels were evaluated at follow-up visits. Mean trough levels for adolescents (12-<18 years) were 2.7 IU/dL. 50% fewer for adults and adolescents if previously dosed every other day.

Novoeight® Important Safety Information

Who should not use Novoeight®?
  • You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins
What is the most important information I need to know about Novoeight®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia center
  • Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands

What is Novoeight®?

Novoeight® (antihemophilic factor, recombinant) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery

  • Novoeight® is not used to treat von Willebrand Disease

Important Safety Information (cont'd)

What should I tell my healthcare provider before using Novoeight®?
  • Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®
What are the possible side effects of Novoeight®?
  • Common side effects of Novoeight® include inhibitors in patients who were not previously treated with factor VIII products, swelling or itching at the location of injection, and fever
Please click here for Prescribing Information for Novoeight®.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


 

Esperoct® Important Safety Information

Who should not use Esperoct®?
  • You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins
What is the most important information I need to know about Esperoct®?
  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center
  • Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face

What is Esperoct®?

Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery

  • Esperoct® is not used to treat von Willebrand Disease

Important Safety Information (cont'd)

What should I tell my healthcare provider before using Esperoct®?
  • Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
  • Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct®
What are the possible side effects of Esperoct®?
  • Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion
Please click here for Prescribing Information for Esperoct®.

Esperoct® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.